Manning cleared of doping allegations in documentary: NFL
Reuters
Published Jul 25, 2016 11:59AM ET
Manning cleared of doping allegations in documentary: NFL
(Reuters) - There is no credible evidence that future Hall of Fame quarterback Peyton Manning used human growth hormone or performance-enhancing drugs as was alleged in an Al-Jazeera documentary, the National Football League said on Monday.
Manning, who retired at the end of last season after leading the Denver Broncos to a Super Bowl win over the Carolina Panthers, had denied allegations made in the documentary that he took human growth hormone while recovering from neck surgery in 2011.
The NFL said in a statement that the Mannings were fully cooperative with the investigation and provided both interviews and access to all records sought by the investigators.
The Al-Jazeera report, released in December, alleged that Manning's wife received deliveries of HGH at their home in 2011 while he was recovering from surgery while playing for the Indianapolis Colts.
The investigation was led by the NFL’s security and legal teams with support from expert consultants and other professionals.
While Manning, a five-times NFL most valuable player, was cleared the league said it would continue to investigate allegations made against other players.
Manning was the most prominent of the names mentioned in the report which also implicated Green Bay's Clay Matthews and Julius Peppers, former Packer Mike Neal and James Harrison of the Pittsburgh Steelers.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.